{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T10:46:45Z","timestamp":1774349205893,"version":"3.50.1"},"reference-count":35,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J of Rheum Dis"],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Musculoskeletal ultrasound (MSUS) provides valuable information about disease activity and anatomical damage in rheumatoid arthritis (RA); therefore, in combination with clinical assessment, it may be a useful tool in clinical decision\u2010making with treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objectives<\/jats:title><jats:p>(1) To evaluate the impact of MSUS assessment on treatment decisions in patients with moderately active RA receiving conventional synthetic disease\u2010modifying antirheumatic drugs (csDMARDs). (2) To determine the level of concordance between MSUS assessment and DAS28 in these patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>RA patients with a DAS\u201028 ranging from 3.22\u20135.1, inadequate response to csDMARDs, and indication for escalating treatment were enrolled. All patients underwent an ultrasound (US) examination (B and PD modes) of the bilateral 5\u2010joint count (5USJC), the symptomatic joints of the DAS\u201028 score (28USJC), and of a comprehensive 78\u2010joint count (78USJC). A Likert scale (pre\u2010 and post\u2010MSUS) was used to assess patients' and clinicians' desires to escalate treatment. The outcome of the treatment decision based on US assessment was reviewed at 24\u2009months' follow\u2010up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 27 patients included, the mean (SD) DAS\u201028 score was 4.4 (0.7). Following US assessment, there was a change in the decision to escalate treatment in 18 patients (66.7%), and at a median follow\u2010up of 24\u2009months, only in 5 of the 18 patients had the treatment had been escalated. Treatment escalation was associated with a higher US score across all assessments (5USJC, 28USJC, 78USJC) (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.05). The 78USJC was the most reliably aligned with the treatment decision (<jats:italic>p<\/jats:italic>\u2009=\u20090.009). A comparison of the US and clinical assessment revealed poor concordance between all variables of the DAS\u201028 and US scores, except for the swollen joint count.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The addition of MSUS assessment to the DAS\u201028 score affected management decisions in 66.7% of patients.<\/jats:p><\/jats:sec>","DOI":"10.1111\/1756-185x.70415","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T06:59:27Z","timestamp":1758869967000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Musculoskeletal Ultrasound Assessment Changes Management Decisions in Rheumatoid Arthritis Patients With Moderate Disease Activity"],"prefix":"10.1111","volume":"28","author":[{"given":"Helena","family":"Crawshaw","sequence":"first","affiliation":[{"name":"Rheumatology Department Gloucestershire Hospitals NHS Foundation Trust  Gloucester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Rubio\u2010Cirilo","sequence":"additional","affiliation":[{"name":"Preventive Medicine Vithas Group Hospitals  Madrid Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilary","family":"Johnson","sequence":"additional","affiliation":[{"name":"Rheumatology Department Gloucestershire Hospitals NHS Foundation Trust  Gloucester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Safwan","family":"Jamal","sequence":"additional","affiliation":[{"name":"Rheumatology Department Gloucestershire Hospitals NHS Foundation Trust  Gloucester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Hickey","sequence":"additional","affiliation":[{"name":"Rheumatology Department Gloucestershire Hospitals NHS Foundation Trust  Gloucester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Gunn","sequence":"additional","affiliation":[{"name":"Rheumatology Department Gloucestershire Hospitals NHS Foundation Trust  Gloucester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iman","family":"Ali","sequence":"additional","affiliation":[{"name":"Rheumatology Department Gloucestershire Hospitals NHS Foundation Trust  Gloucester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gill","family":"Coombes","sequence":"additional","affiliation":[{"name":"Rheumatology Department Gloucestershire Hospitals NHS Foundation Trust  Gloucester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8000-6520","authenticated-orcid":false,"given":"Carlos","family":"Acebes","sequence":"additional","affiliation":[{"name":"Rheumatology Department Gloucestershire Hospitals NHS Foundation Trust  Gloucester UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2025,9,25]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keac210"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2022-223356"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.24596"},{"key":"e_1_2_10_5_1","first-page":"279","article-title":"2014 Update of the Consensus Statement of the Spanish Society of Rheumatology on the Use of Biological Therapies in Rheumatoid Arthritis","volume":"11","author":"Sanmart\u00ed R.","year":"2015","journal-title":"Reumatologia Clinica"},{"key":"e_1_2_10_6_1","first-page":"1693","article-title":"Adherence of Italian Rheumatologists to the EULAR Recommendations and Outcomes in Early Rheumatoid Arthritis Patients After Starting Conventional DMARDs: Methotrexate in Italian Patients With Rheumatoid Arthritis (The MITRA Study). A Cohort Study of the Italian Society for Rheumatology","volume":"40","author":"Fornaro M.","year":"2022","journal-title":"Clinical and Experimental Rheumatology"},{"key":"e_1_2_10_7_1","unstructured":"NICE National Institute for Health and Care Excellence \u201cAdalimumab etanercept infliximab and abatacept for treating moderate rheumatoid arthritis after conventional DMARDs have failed \u201d(2021) https:\/\/www.nice.org.uk\/guidance\/ta715."},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780380107"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-018-4096-z"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1186\/s42358-021-00214-3"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38304"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez049"},{"key":"e_1_2_10_13_1","first-page":"470","article-title":"The Relation Between Composite Ultrasound Measures and the DAS\u201028 Score, Its Components in Acute Phase Markers in Adult RA","volume":"47","author":"Hameed B.","year":"2008","journal-title":"Rheumatology (Oxford, England)"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep171"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev305"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22218"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203158"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110424"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211585"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.181095"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000000469"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep458"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-016-1258-6"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-201048"},{"key":"e_1_2_10_25_1","first-page":"S673","article-title":"Effect of Musculoskeletal Ultrasound Examination on Therapeutic Decision Making in Inflammatory Arthritis","volume":"62","author":"Ceponis A.","year":"2010","journal-title":"Arthritis & Rheumatism"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-208941"},{"key":"e_1_2_10_27_1","article-title":"Ultrasound in Management of Rheumatoid Arthritis: ARCTIC Randomised Controlled Strategy Trial","volume":"354","author":"Haavardsholm E. A.","year":"2016","journal-title":"BMJ (Clinical Research Ed.)"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3689-2"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22119"},{"key":"e_1_2_10_30_1","article-title":"The Added Value of Musculoskeletal Ultrasound to Clinical Evaluation in the Treatment Decision of Rheumatoid Arthritis Outpatients: Physician Experience Matters","volume":"18","author":"Sifuentes\u2010Cant\u00fa C","year":"2017","journal-title":"BMC"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.5152\/eurjrheum.2020.20038"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker255"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215321"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2016-000427"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24646"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/0284185118773507"}],"container-title":["International Journal of Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/1756-185x.70415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T03:11:06Z","timestamp":1759201866000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/1756-185x.70415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["10.1111\/1756-185x.70415"],"URL":"https:\/\/doi.org\/10.1111\/1756-185x.70415","archive":["Portico"],"relation":{},"ISSN":["1756-1841","1756-185X"],"issn-type":[{"value":"1756-1841","type":"print"},{"value":"1756-185X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"2025-03-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-12","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-25","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70415"}}